Pedigree of the occurrence of protein S deficiency (PSD) in the kindred of the patient (the propositus (II-5), indicated by the arrow). Various types of circulation disorder were found in this pedigree, including deep vein thrombosis (II-1, II-2, and II-5) and brain infarction (I-2, II-2, and II-5). Blood test confirmed the presence of protein S deficiency in the propositus (II-5), the first sibling (patient II-1), the second sibling (patient II-2), and his son (III-1). In I-2 and II-1 (gray circles), protein S deficiency has not yet been documented by blood test. , male without PSD; , female without PSD; , male with PSD. Numbers in the parentheses are functional protein S activity of the propositus determined in 1994 at age 52 years (normal range, 60-150%; see Table 1 ). stenotic lesion of the right coronary artery). Left ventriculography showed hypokinesis in the anterior wall and akinesis in the inferior wall. Because of the angiographical delay along the LAD and the abnormal Q wave in leads II, III and aVF, the LAD was thought to be the culprit artery for the current heart attack. Under the support of intra-aortic balloon pumping, the stenotic lesion of the LAD was successfully dilated to less than 25% by balloon angioplasty without angiographical delay. Three days later, his hemodynamic status stabilized without the support of the intraaortic balloon pumping. The maximal plasma level of CK and its cardiospecific isozyme, CK-MB, after the angioplasty, were 1,801 and 186.8 IU/L, respectively. Prior to this admission, the patient had suffered from his long history of circulation disorders: deep vein thrombosis in his left leg at 45 years old, brain infarction causing paralysis of his left leg at 46 years old, and inferior myocardial infarction at 52 years old. Similar symptoms were found in his relatives (Fig 1) : brain infarction in his mother (I-2), deep vein thrombosis in his elder sister (II-1), deep vein thrombosis and left hemiplegia due to brain infarction in his elder brother (II-2). A congenital abnormality in blood coagulation was suspected in this pedigree. Blood tests performed in 1994 when the patient was 52 years old revealed a low activity of protein S (Fig 1) . Since then the propositus had been administered warfarin, an oral anticoagulant, to prevent further circulation disorders.
To confirm the functional abnormality of protein S in the propositus, his blood was sampled 3 months after the second heart attack. To exclude the effect of warfarin on the blood test, it was suspended 2 weeks prior to the blood sampling and during the 2-week suspension, heparin was administered intravenously to reduce the risk of additional circulation disorders. Total protein S antigen, 1 free protein S antigen 15 and functional protein S activity 16 were measured according to the manufacturer's instructions (Roche diagnostics, Tokyo). Antithrombin III activity, 18 functional protein C activity 19 and protein C antigen were measured according to the manufacturer's instructions (Daiiti-kagakuyakuhin, Sismex, and Iatron Laboratories, Inc, respectively). Although the total amount of protein S antigen was 65% (at around the lower limit of normal), the level of free protein S antigen was significantly low (31%). Functional protein S activity was less than 10%. Other factors influencing blood coagulation were within normal range, including anti-thrombin III and protein C (Table 1) . Besides the propositus (II-5), blood sample were obtained from II-2, II-6, III-1 and III-2, and protein S deficiency was confirmed in II-2 and III-1 (Fig 1) .
Discussion
Hereditary protein S deficiency is a well-known risk factor not only for venous thrombosis but also for arterial thrombosis including AMI, [8] [9] [10] [11] [12] stroke 13 and peripheral artery thrombosis. 14 In those reports, the patients were young or middle aged (17-55 years old) and their coronary arteries appeared to be devoid of organic stenosis although they were occluded with some thrombus, [10] [11] [12] which suggests a crucial role of thrombophilia in the catastrophic growth of thrombus in the intracoronary lumen.
The present patient experienced the first heart attack at age 52 and the second one at age 58 years. Cardiac catheterization showed severe coronary arteriosclerosis (ie, triple vessel disease), although he did not have any conventional coronary risk factors. Because of his long history of deep vein thrombosis, warfarin had been prescribed since he was 52 years old and the prothrombin time test on his present admission revealed an international normalized ratio (INR) of 1.93. This raises the interesting question of whether protein S deficiency is a novel risk factor for the progression of coronary atherosclerosis. Even under warfarin therapy, microthrombi might repeatedly form in the coronary arteries and we suspect that such a process would facilitate the progression of coronary atherosclerosis.
The genetic analyses of patients with protein S deficiency, including that of the propositus, were performed by the single-strand conformational analysis followed by DNA sequencing. Using this technique, 11 unrelated thrombophilic Japanese families with protein S deficiency were investigated and we successfully identified 3 missense mutations in 3 patients with protein S deficiency. 17 The mutation in the propositus, however, was not identified, partly because of the presence of the 97% homologous pseudogene. An alternative possibility is that the mutation of the propositus was inversion or a gross deletion of the protein S gene that could not be identified by the polymerase chain reaction method used at that time.
This case report contributes to the better understanding of the role of thrombophilia, including protein S deficiency, in the etiology not only of venous thrombosis but also of arterial circulation disorders.
